Search

Search Constraints

You searched for: Author/Creator Lehrke, Michael

Search Results

11. Human and mouse non‐targeted metabolomics identify 1, 5‐anhydroglucitol as SGLT2‐dependent glycemic marker. Issue 6 (27th June 2021)

12. Interleukin-1α Is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney Disease. Issue 11 (14th September 2021)

13. Interleukin-1α Is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney Disease. Issue 11 (1st July 2021)

14. Interleukin-6 predicts inflammation-induced increase of Glucagon-like peptide-1 in humans in response to cardiac surgery with association to parameters of glucose metabolism. Issue 1 (December 2016)

15. Loss of CASK Accelerates Heart Failure Development. Issue 8 (17th February 2021)

16. Myocardial infarction is sufficient to increase GLP‐1 secretion, leading to improved left ventricular contractility and mitochondrial respiratory capacity. Issue 12 (16th August 2018)

17. Native, Intact Glucagon-Like Peptide 1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions. Issue 3 (March 2020)

18. Non‐targeted metabolomics identify polyamine metabolite acisoga as novel biomarker for reduced left ventricular function. (22nd November 2021)

19. PDE4 inhibition reduces neointima formation and inhibits VCAM-1 expression and histone methylation in an Epac-dependent manner. (April 2015)

20. Post-cardiac injury syndrome after transcatheter mitral valve repair using MitraClip system: a case report. Issue 4 (21st July 2020)